JAK2 V617F对原发性血小板增多症患者血栓形成风险的影响：衡量不确定性。 - Suppr

Suppr

超能文献

Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia: measuring the uncertain.

作者信息

Ziakas Panayiotis D

出版信息

Haematologica. 2008 Sep;93(9):1412-4. doi: 10.3324/haematol.12970. Epub 2008 Jul 18.

DOI:10.3324/haematol.12970

PMID:18641024

Abstract

摘要

相似文献

Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia: measuring the uncertain.JAK2 V617F对原发性血小板增多症患者血栓形成风险的影响：衡量不确定性。

Haematologica. 2008 Sep;93(9):1412-4. doi: 10.3324/haematol.12970. Epub 2008 Jul 18.

Reemergence of JAK2 V617F clone heralds extramedullary leukemia relapse after BMT for transformed essential thrombocytosis.JAK2 V617F克隆的再次出现预示着转化型原发性血小板增多症在进行异基因骨髓移植后髓外白血病复发。

Ann Hematol. 2007 Feb;86(2):145-7. doi: 10.1007/s00277-006-0213-2. Epub 2006 Nov 17.

Leukocytosis is linked to thrombosis at diagnosis, while JAK2 V617F mutation is associated with thrombosis during the course of essential thrombocythemia.白细胞增多症与诊断时的血栓形成有关，而JAK2 V617F突变与原发性血小板增多症病程中的血栓形成有关。

Int J Hematol. 2008 May;87(4):446-448. doi: 10.1007/s12185-008-0080-9.

Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation.携带 JAK2 V617F 突变纯合子的原发性血小板增多症患者复发性血栓形成风险增加。

Ann Hematol. 2010 Feb;89(2):141-6. doi: 10.1007/s00277-009-0788-5. Epub 2009 Jul 7.

JAK2 V617F: implications for thrombosis in myeloproliferative diseases.JAK2 V617F：对骨髓增殖性疾病中血栓形成的影响

Curr Opin Hematol. 2007 Sep;14(5):450-4. doi: 10.1097/MOH.0b013e3282861d1b.

Clinical relevance of JAK2 (V617F) mutant allele burden.JAK2（V617F）突变等位基因负荷的临床相关性。

Haematologica. 2009 Jan;94(1):7-10. doi: 10.3324/haematol.2008.001271.

JAK2 V617F and ringed sideroblasts: not necessarily RARS-T.

Blood. 2008 Feb 1;111(3):1748. doi: 10.1182/blood-2007-11-121608.

JAK2 V617F, hemostatic polymorphisms, and clinical features as risk factors for arterial thrombotic events in essential thrombocythemia.JAK2 V617F、止血多态性及临床特征作为原发性血小板增多症患者动脉血栓形成事件的危险因素

Ann Hematol. 2008 Sep;87(9):763-5. doi: 10.1007/s00277-008-0474-z. Epub 2008 Mar 26.

Most pediatric patients with essential thrombocythemia show hypersensitivity to erythropoietin in vitro, with rare JAK2 V617F-positive erythroid colonies.大多数原发性血小板增多症的儿科患者在体外对促红细胞生成素表现出超敏反应，JAK2 V617F阳性红系集落罕见。

Leuk Res. 2008 Mar;32(3):369-77. doi: 10.1016/j.leukres.2007.07.011. Epub 2007 Aug 23.

JAK2 V617F-positive essential thrombocythemia in a patient with Klinefelter syndrome: a case report.

Cancer Genet Cytogenet. 2010 Apr 15;198(2):162-5. doi: 10.1016/j.cancergencyto.2010.01.001.

引用本文的文献

PNH clones prevalence study in ph-negative myeloproliferative neoplasms: a multicenter Italian study.阴性骨髓增殖性肿瘤中阵发性睡眠性血红蛋白尿克隆患病率研究：一项意大利多中心研究。

Ann Hematol. 2025 Aug 22. doi: 10.1007/s00277-025-06556-y.

Downregulated KLF2 in polycythemia vera and essential thrombocythemia induces prothrombotic gene expression.KLF2 在真性红细胞增多症和原发性血小板增多症中下调，诱导促血栓形成基因表达。

Blood Adv. 2023 Mar 14;7(5):712-717. doi: 10.1182/bloodadvances.2022008052.

Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms.血小板在慢性骨髓增殖性肿瘤中的血栓炎症中介作用。

Front Immunol. 2019 Jun 14;10:1373. doi: 10.3389/fimmu.2019.01373. eCollection 2019.

Expression of CD markers in JAK2 positive myeloproliferative neoplasms: Prognostic significance.JAK2 阳性骨髓增殖性肿瘤中 CD 标志物的表达：预后意义。

Oncol Rev. 2018 Oct 2;12(2):373. doi: 10.4081/oncol.2018.373. eCollection 2018 Jul 4.

Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms.骨髓增殖性肿瘤相关静脉血栓栓塞症的抗血栓治疗。

Blood Cancer J. 2018 Jun 26;8(7):65. doi: 10.1038/s41408-018-0101-8.

Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms.费城阴性经典骨髓增殖性肿瘤中的血栓形成：流行病学、风险评估和病理生理机制的叙述性综述。

J Thromb Thrombolysis. 2018 May;45(4):516-528. doi: 10.1007/s11239-018-1623-4.

Risk Factors for and Management of MPN-Associated Bleeding and Thrombosis.骨髓增殖性肿瘤相关出血和血栓形成的危险因素及管理

Curr Hematol Malig Rep. 2017 Oct;12(5):389-396. doi: 10.1007/s11899-017-0400-3.

A portable microfluidic platform for rapid molecular diagnostic testing of patients with myeloproliferative neoplasms.一种便携式微流控平台，用于快速对骨髓增殖性肿瘤患者进行分子诊断测试。

Sci Rep. 2017 Aug 17;7(1):8596. doi: 10.1038/s41598-017-08674-8.

Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era.评估基因组时代原发性血小板增多症患者的血栓形成风险。

Leukemia. 2017 Sep;31(9):1845-1854. doi: 10.1038/leu.2017.150. Epub 2017 May 22.

Is JAK2V617F Mutation the Only Factor for Thrombosis in Philadelphia-Negative Chronic Myeloproliferative Neoplasms?JAK2V617F突变是费城染色体阴性慢性骨髓增殖性肿瘤中血栓形成的唯一因素吗？

Indian J Hematol Blood Transfus. 2016 Sep;32(3):262-7. doi: 10.1007/s12288-015-0578-2. Epub 2015 Aug 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验